Cambridge Healthtech Institute’s Third Annual
Biophysical Analysis of Biotherapeutics
Characterizing the Physical Properties of Proteins in the Research and Development of Next Generation Protein Therapeutics
Part of the 11th Annual PEGS: the essential protein engineering summit
May 6-7, 2015 | World Trade Center | Boston, Massachusetts

Biophysical analysis is now playing a significant role in the research and early development for a new generation of complex protein therapeutics. The combination of improved understandings of the structure and function of proteins with advanced, higher resolution analytical methods helps researchers identify and fine-tune candidate molecules before advancing them into development. As protein engineers and analytical scientists increase their reliance on biophysical analysis, they are driving a move to instruments with higher throughput and resolution – and working to quantify analytical results previously used only for qualitative assessments. The Biophysical Analysis meeting at PEGS will bring together an international audience of protein scientists and analytical specialists to explore the latest technologies and techniques used for problem solving in this dynamic field.

Topics may include, but are not limited to: 

  • Assays for developability evaluation
  • Biophysical analysis of high concentration proteins
  • Biophysical assay qualification and validation
  • Emerging instruments and analytical methods
  • Engineering solutions to biophysical liabilities
  • Formulation solutions to biophysical liabilities
  • Have biophysical methods reached the saturation point of resolution?
  • Miniaturization of biophysical assays
  • Multiplexing and parallelization of biophysical analytical methods
  • Predictive modeling for biophysical characteristics
  • Spectroscopic methods for biophysical analysis
  • Surrogate assays for prediction of aggregation propensity

Scientists who wish to present their knowledge and expertise to their colleagues are asked to click here to submit an abstract. Remember to specify the conference that you are interested in and please provide your full contact information.

Deadline for submission is October 3, 2014. 

All proposals are subject to review by the Scientific Advisory Committee to ensure the highest quality of the conference program. Please note that due to limited speaking slots, preference is given to pharmaceutical and biotech companies, regulators and those from academia. Additionally, vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships. 

For more details on the conference, please contact:
Kent Simmons
Program Director
Cambridge Healthtech Institute
Phone: 207-869-9199

For partnering and sponsorship information, please contact:
Jason Gerardi (Companies A-K)
Manager, Business Development
Cambridge Healthtech Institute
T: 781-972-5452

Carol Dinerstein (Companies L-Z)
Director, Business Development
Cambridge Healthtech Institute
T: 781.972.5471